Mitali Alone
0000-0001-6928-2665
1 paper found
Refreshing results…
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation
Missing publications? Search for publications with a matching author name.